Sanofi has received European Commission approval for subcutaneous Sarclisa, or isatuximab, in combination with standard-...
MEDIPOST has secured FDA agreement to conduct a single pivotal Phase III study for CARTISTEM in the US, marking an impor...
Pfizer has received US FDA approval for an expanded indication of Hympavzi for hemophilia A or B, broadening its use to ...
Shionogi has received US FDA approval for XOCOVA, or ensitrelvir, as an oral post-exposure prophylaxis option for COVID-...
VERTANICAL has received marketing authorisation in Germany for Exilby, or VER-01, for the treatment of chronic low back ...
Genentech has received US FDA approval for Tecentriq and Tecentriq Hybreza as adjuvant treatment for adults with muscle-...
The European Medicines Agency has accepted Teva’s Marketing Authorisation Application for olanzapine long-acting i...
Amgen has received European Commission marketing authorisation for IMDYLLTRA, or tarlatamab, as monotherapy for adults w...
AbbVie has received European Commission approval for AQUIPTA, or atogepant, as an acute treatment for migraine in adults...
Vertex Pharmaceuticals has received US FDA acceptance of its Biologics License Application for accelerated approval of p...
Omnix Medical, a biopharmaceutical company developing next-generation anti-infectives for severe multidrug-resistant inf...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced the Thermo Scientific Orbitrap...
MSD, trade name of Merck & Co., Inc., Rahway, N.J., USA, has announced that the Health Sciences Authority (HSA) of S...
On May 15, 2026, China’s National Medical Products Administration (“NMPA”) issued the Implementat...
Nutraceutical ingredients innovator SUANNUTRA USA has inked a distribution agreement with Spanish biotech company Fitopl...
Antimicrobial resistance (AMR) continues to be recognised as one of the world’s most pressing ...
In his keynote session, Heath Coats shared practical regulatory insights drawn from his experience both ...
The InnoHK Centre for Neuromusculoskeletal Restorative Medicine (CNRM), established by The Chinese University of Hong Ko...
A new combination therapy has shown promise in extending survival for patients with a specific type of lung cancer in As...
India-based Zydus Lifesciences (including its subsidiaries and affiliates), has signed an exclusive development, licensi...
Pfizer’s NURTEC® (rimegepant), an orally disintegrating tablet for both the acute treatment of migraine is now...
Shanghai Junshi Biosciences Co. has collaborated with Indian pharmaceutical firm Dr. Reddy’s Laboratories to devel...
GSK Singapore announced that Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5...
Japan headquatered Takeda's EXKIVITY (mobocertinib) has been approved by the National Medical Products Administration (N...
The current diabetic neuropathic pain treatment paradigm includes many established analgesics that provide sym...
